Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Faron Pharmaceuticals Oy (GB:FARN)
LSE:FARN
RESEARCH TOOLSreports
Faron Pharmaceuticals Oy (FARN) Share Price & Analysis
16 Followers
FARN Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range85.00p - 306.08p
Previous Close137.5p
Volume565.63K
Average Volume (3M)82.22K
Market Cap
£140.00M
Enterprise Value145.27M
Total Cash (Recent Filing)€6.99M
Total Debt (Recent Filing)€13.27M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Aug 27, 2024EPS Estimate
-£0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding72,007,497
10 Day Avg. Volume120,452
30 Day Avg. Volume82,222
Standard Deviation0.26
R-Squared0.06
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)-7.83
Price to Sales (P/S)39904.53
Price to Cash Flow (P/CF)-3.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
1,000.00pPrice Target Upside627.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Faron Pharmaceuticals Oy News
PremiumCompany Announcements
Faron Pharmaceuticals Gains FDA Nod for Bexmarilimab Study
PremiumCompany Announcements
Faron Pharmaceuticals Completes Major Share Offering
PremiumCompany Announcements
Faron Pharmaceuticals Corrects Shareholding Data
PremiumCompany Announcements
Faron Pharmaceuticals Stakeholder Increases SharesPremiumCompany Announcements
Faron Pharmaceuticals Reports Major Holdings ShiftPremiumCompany Announcements
Faron Pharmaceuticals Ownership Shake-Up
PremiumCompany Announcements
Faron Pharmaceuticals Oy Reports Major Shareholding ChangePremiumCompany Announcements
Faron Pharmaceuticals Issues New SharesOptions Prices
Currently, No data available
---
Ownership Overview
5.55% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
94.45% Public Companies and
Individual Investors
FARN FAQ
What was Faron Pharmaceuticals Oy’s price range in the past 12 months?
Faron Pharmaceuticals Oy lowest share price was 85.00p and its highest was 306.08p in the past 12 months.
What is Faron Pharmaceuticals Oy’s market cap?
Currently, no data Available
When is Faron Pharmaceuticals Oy’s upcoming earnings report date?
Faron Pharmaceuticals Oy’s upcoming earnings report date is Aug 27, 2024 which is in 42 days.
How were Faron Pharmaceuticals Oy’s earnings last quarter?
Faron Pharmaceuticals Oy released its earnings results on Mar 13, 2024. The company reported -0.181p earnings per share for the quarter, missing the consensus estimate of -0.136p by -0.045p.
Is Faron Pharmaceuticals Oy overvalued?
According to Wall Street analysts Faron Pharmaceuticals Oy’s price is currently Undervalued.
Does Faron Pharmaceuticals Oy pay dividends?
Faron Pharmaceuticals Oy does not currently pay dividends.
What is Faron Pharmaceuticals Oy’s EPS estimate?
Faron Pharmaceuticals Oy’s EPS estimate is -£0.18.
How many shares outstanding does Faron Pharmaceuticals Oy have?
Faron Pharmaceuticals Oy has 102,867,850 shares outstanding.
What happened to Faron Pharmaceuticals Oy’s price movement after its last earnings report?
Faron Pharmaceuticals Oy reported an EPS of -0.181p in its last earnings report, missing expectations of -0.136p. Following the earnings report the stock price went up 7.405%.
Which hedge fund is a major shareholder of Faron Pharmaceuticals Oy?
Currently, no hedge funds are holding shares in GB:FARN
---
Faron Pharmaceuticals Oy Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
1,000.00p (627.27% Upside)
1,000.00p (627.27% Upside)
Insider Transactions
Bought Shares
Worth £38.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.30%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-11.44%
Trailing 12-Months
Company Description
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. The company has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy in phase I/II development as a novel macrophage checkpoint immunotherapy for patients with untreatable solid tumours, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Traumakine, the company's investigational intravenous interferon beta-1a is a anti-viral and anti-inflammatory agent, being tested in several Phase III studies around the world against COVID-19.
---
FARN Stock 12 Month Forecast
Average Price Target
1,000.00p
▲(627.27% Upside)
Technical Analysis
Allergy Therapeutics
―
Avacta Group plc
―
HUTCHMED (China) Limited
―
EKF Diagnostics Holdings
―
OptiBiotix Health
―
Best Analysts Covering FARN
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-20.97%
reiterated a buy rating 5 days ago
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -20.97% per trade.
---